Inventor
Russell Dahl
Inventor
Carlsbad, CA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes23%
C07CAcyclic or carbocyclic compounds5%
Y02ATechnologies for adaptation to climate change5%
C07JSteroids4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
10,800,766Quinoline alkenes as cytoprotective agents202010,793,558Quinoline oxadiazoles as cytoprotective agents202010,772,881Quinolines that modulate SERCA and their use for treating disease202010,730,839Quinolines as cytoprotective agents202010,730,843Quinoxalines useful as cytoprotective agents202010,501,453Benzothiazole or benzoxazole compounds as SUMO activators201910,383,867Quinoline derivatives and their use for treating endoplasmic reticulum stress-related diseases and disorders201910,383,868Quinoline containing compounds and their use for treating endoplasmic reticulum stress-related diseases201910,370,333Sulfonamide compounds and uses as TNAP inhibitors201910,099,993Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof201810,011,578Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release20189,884,826'Sulfonamide compounds and uses as TNAP inhibitors'20189,845,320Benzothiazole or benzoxazole compounds as sumo activators20179,725,429'Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium release'20179,458,147'Sulfonamide compounds and uses as TNAP inhibitors'20169,102,645'Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release'20157,919,617'Cytokine inhibitors'20117,897,599'Cytokine inhibitors'20117,888,355'Compositions and methods for inhibiting growth and metastasis of melanoma'20117,776,894'Compositions and methods for inhibiting growth and metastasis of melanoma'20107,749,999'Alpha-ketoamides and derivatives thereof'20106,924,284'PARP inhibitors'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2019Based in Carlsbad, CA, US· patent location history
2010–2011Patents assigned to ITHERX PHARMACEUTICALS INC (3)· patent assignee history
2010–2011Patents assigned to BURNHAM INST MEDICAL RESEARCH (2)· patent assignee history
2015–2018Patents assigned to UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE (3)· patent assignee history
2015–2018Based in North Chicago, IL, US· patent location history
2016–2019Based in La Jolla, CA, US· patent location history
2017–2019Patents assigned to ICAHN SCHOOL MED MOUNT SINAI (2)· patent assignee history
2019–2020Patents assigned to DAHL RUSSELL (7)· patent assignee history
2019–2020Based in St. John, IN, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DAHL RUSSELLself | 7 | 2019–2020 |
| ITHERX PHARMACEUTICALS INC | 3 | 2010–2011 |
| UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE | 3 | 2015–2018 |
| BURNHAM INST MEDICAL RESEARCH | 2 | 2010–2011 |
| ICAHN SCHOOL MED MOUNT SINAI | 2 | 2017–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Carlsbad, California, US | 8 | 2005–2019 |
| St. John, IN, US | 7 | 2019–2020 |
| La Jolla, California, US | 4 | 2016–2019 |
| North Chicago, Illinois, US | 3 | 2015–2018 |